Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 1
2014 1
2016 1
2017 1
2018 2
2020 2
2021 2
2022 3
2023 2
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean waive study team[Corporate Author] (5 results)?
Safety and efficacy of zilucoplan in patients with generalised myasthenia gravis (RAISE): a randomised, double-blind, placebo-controlled, phase 3 study.
Howard JF Jr, Bresch S, Genge A, Hewamadduma C, Hinton J, Hussain Y, Juntas-Morales R, Kaminski HJ, Maniaol A, Mantegazza R, Masuda M, Sivakumar K, Śmiłowski M, Utsugisawa K, Vu T, Weiss MD, Zajda M, Boroojerdi B, Brock M, de la Borderie G, Duda PW, Lowcock R, Vanderkelen M, Leite MI; RAISE Study Team. Howard JF Jr, et al. Lancet Neurol. 2023 May;22(5):395-406. doi: 10.1016/S1474-4422(23)00080-7. Lancet Neurol. 2023. PMID: 37059508 Clinical Trial.
Two-step egg introduction for prevention of egg allergy in high-risk infants with eczema (PETIT): a randomised, double-blind, placebo-controlled trial.
Natsume O, Kabashima S, Nakazato J, Yamamoto-Hanada K, Narita M, Kondo M, Saito M, Kishino A, Takimoto T, Inoue E, Tang J, Kido H, Wong GW, Matsumoto K, Saito H, Ohya Y; PETIT Study Team. Natsume O, et al. Lancet. 2017 Jan 21;389(10066):276-286. doi: 10.1016/S0140-6736(16)31418-0. Epub 2016 Dec 9. Lancet. 2017. PMID: 27939035 Clinical Trial.
In this study, we developed a practical approach to overcome the second wave of the allergic epidemic caused by food allergy. FUNDING: Ministry of Health, Labour and Welfare, and National Centre for Child Health and Development, Japan....
In this study, we developed a practical approach to overcome the second wave of the allergic epidemic caused by food allergy. FUNDING …
Propofol enhancement of slow wave sleep to target the nexus of geriatric depression and cognitive dysfunction: protocol for a phase I open label trial.
Rios RL, Green M, Smith SK, Kafashan M, Ching S, Farber NB, Lin N, Lucey BP, Reynolds CF, Lenze EJ, Palanca BJA; SWIPED Study Team. Rios RL, et al. BMJ Open. 2024 May 30;14(5):e087516. doi: 10.1136/bmjopen-2024-087516. BMJ Open. 2024. PMID: 38816055 Free PMC article.
Impaired sleep is common in LL-TRD and is a risk factor for cognitive decline. Slow wave sleep (SWS) has been implicated in key processes including synaptic plasticity and memory. ...Sleep EEG recordings are scored manually. Key EEG measures include sleep slow wave …
Impaired sleep is common in LL-TRD and is a risk factor for cognitive decline. Slow wave sleep (SWS) has been implicated in key proce …
Safety and Efficacy of Topiramate in Individuals With Cryptogenic Sensory Peripheral Neuropathy With Metabolic Syndrome: The TopCSPN Randomized Clinical Trial.
Smith AG, Singleton JR, Aperghis A, Coffey CS, Creigh P, Cudkowicz M, Conwit R, Ecklund D, Fedler JK, Gudjonsdottir A, Hauer P, Herrmann DN, Kearney M, Kissel J, Klingner E, Quick A, Revere C, Stino A; NeuroNEXT NN108 TopCSPN Study Team. Smith AG, et al. JAMA Neurol. 2023 Dec 1;80(12):1334-1343. doi: 10.1001/jamaneurol.2023.3711. JAMA Neurol. 2023. PMID: 37870862 Free PMC article. Clinical Trial.
Examining amyloid reduction as a surrogate endpoint through latent class analysis using clinical trial data for dominantly inherited Alzheimer's disease.
Wang G, Li Y, Xiong C, Benzinger TLS, Gordon BA, Hassenstab J, Aschenbrenner AJ, McDade E, Clifford DB, Libre-Guerra JJ, Shi X, Mummery CJ, van Dyck CH, Lah JJ, Honig LS, Day G, Ringman JM, Brooks WS, Fox NC, Suzuki K, Levin J, Jucker M, Delmar P, Bittner T, Bateman RJ; DIAN‐TU Study Team. Wang G, et al. Alzheimers Dement. 2024 Apr;20(4):2698-2706. doi: 10.1002/alz.13735. Epub 2024 Feb 23. Alzheimers Dement. 2024. PMID: 38400532 Free PMC article.
Recruitment outcomes, challenges and lessons learned: the Healthy Communities Study.
Sagatov RDF, John LV, Gregoriou M, Arteaga SS, Weber S, Payn B, Strauss W, Weinstein N, Collie-Akers V; Healthy Communities Study Team. Sagatov RDF, et al. Pediatr Obes. 2018 Oct;13 Suppl 1(Suppl 1):27-35. doi: 10.1111/ijpo.12455. Epub 2018 Sep 12. Pediatr Obes. 2018. PMID: 30209890 Free PMC article.
METHODS: Purchased address lists were utilized to select households for recruitment during Wave 1 of the study, and recruitment of families through schools was employed for Wave 2. ...
METHODS: Purchased address lists were utilized to select households for recruitment during Wave 1 of the study, and recruitment of fa …
Comparison between first and second wave of COVID-19 outbreak in older people: the COPE multicentre European observational cohort study.
Verduri A, Short R, Carter B, Braude P, Vilches-Moraga A, Quinn TJ, Collins J, Lumsden J, McCarthy K, Evans L, Myint PK, Hewitt J; COPE Study Team. Verduri A, et al. Eur J Public Health. 2022 Oct 3;32(5):807-812. doi: 10.1093/eurpub/ckac108. Eur J Public Health. 2022. PMID: 35997587 Free PMC article.
Our aim was to compare clinical outcomes for older people with COVID-19 in Wave 1 (W1) and Wave 2 (W2). METHODS: All data, including the Clinical Frailty Scale (CFS), were collected for COVID-19 consecutive patients, aged 65, from 13 hospitals, in W1 (February-June …
Our aim was to compare clinical outcomes for older people with COVID-19 in Wave 1 (W1) and Wave 2 (W2). METHODS: All data, inc …
Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets.
Goodman S, Wadsworth E, Leos-Toro C, Hammond D; International Cannabis Policy Study team. Goodman S, et al. Int J Drug Policy. 2020 Feb;76:102658. doi: 10.1016/j.drugpo.2019.102658. Epub 2020 Jan 9. Int J Drug Policy. 2020. PMID: 31927413
There is little comparative data on product use across jurisdictions, particularly with respect to the types of cannabis products used, which differentially impact health. METHODS: Data are from Wave 1 of the International Cannabis Policy Study, collected from Aug 27-Oct 7 …
There is little comparative data on product use across jurisdictions, particularly with respect to the types of cannabis products used, whic …
Public perceptions and behavioural responses to the first COVID-19 pandemic wave in Italy: results from the iCARE study.
Stojanovic J, Raparelli V, Boccia S, Bacon SL, Lavoie KL; iCARE Study Team. Stojanovic J, et al. Eur J Public Health. 2021 Dec 1;31(6):1270-1277. doi: 10.1093/eurpub/ckab147. Eur J Public Health. 2021. PMID: 34406384 Free PMC article.
Considering that many countries are currently battling the second wave of the pandemic, understanding people's perceptions and responses to government policies remain critical for informing on-going mitigation strategies. ...
Considering that many countries are currently battling the second wave of the pandemic, understanding people's perceptions and respon …
Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study.
Bekker LG, Garrett N, Goga A, Fairall L, Reddy T, Yende-Zuma N, Kassanjee R, Collie S, Sanne I, Boulle A, Seocharan I, Engelbrecht I, Davies MA, Champion J, Chen T, Bennett S, Mametja S, Semenya M, Moultrie H, de Oliveira T, Lessells RJ, Cohen C, Jassat W, Groome M, Von Gottberg A, Le Roux E, Khuto K, Barouch D, Mahomed H, Wolmarans M, Rousseau P, Bradshaw D, Mulder M, Opie J, Louw V, Jacobson B, Rowji P, Peter JG, Takalani A, Odhiambo J, Mayat F, Takuva S, Corey L, Gray GE; Sisonke Protocol Team; Sisonke Study Team. Bekker LG, et al. Lancet. 2022 Mar 19;399(10330):1141-1153. doi: 10.1016/S0140-6736(22)00007-1. Lancet. 2022. PMID: 35305740 Free PMC article.
During the course of the study, the beta (B.1.351) and then the delta (B.1.617.2) SARS-CoV-2 variants of concerns were dominant, and vaccine effectiveness remained consistent (for scheme A plus B vaccine effectiveness against COVID-19-related hospital admission during beta wav …
During the course of the study, the beta (B.1.351) and then the delta (B.1.617.2) SARS-CoV-2 variants of concerns were dominant, and vaccine …
18 results